We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 267

General Court upholds Commission decision in AstraZeneca abuse of dominance case

  • Herbert Smith Freehills LLP
  • -
  • European Union
  • -
  • July 2 2010

The General Court has issued its long awaited judgment in the AstraZeneca case, upholding the Commission's decision in respect of both the SPC abuse and the selective deregistration abuse

SPC update

  • Mewburn Ellis LLP
  • -
  • European Union
  • -
  • February 7 2013

The CJEU continues to receive a steady stream of referrals relating to the scope of protection from Supplementary Protection Certificates (SPCs). The

Agreement to establish the Unified Patent Court signed

  • Baker & McKenzie
  • -
  • European Union
  • -
  • April 3 2013

Further to the news last month regarding the regulations on a unitary patent for Europe, on 19 February 2013, representatives of 24 EU member states

First decision of the ECJ on the Unitary Patent

  • Taylor Wessing LLP
  • -
  • European Union
  • -
  • April 16 2013

Today, the ECJ dismissed the complaints of Spain (C-27411) and Italy (C-29511) against the Council of the European Union with a view to the Unitary

Objections to the unitary patent dismissed by Court of Justice but obstacles still in the path of the unified patent system

  • Herbert Smith Freehills LLP
  • -
  • European Union
  • -
  • April 16 2013

In a decision in Joined cases C-27411 and C-29511 Spain and Italy v Council, published today, the Court of Justice of the European Union (CJEU) has

The ECJ hands down judgment on the scope of protection of biotechnological inventions

  • Herbert Smith Freehills LLP
  • -
  • European Union, United Kingdom
  • -
  • July 7 2010

The ECJ this Tuesday handed down judgment in Case C-42808, Monsanto Technology v Cefetra, a request for a preliminary ruling on the legal protection afforded by the biotechnology Directive to genetic material

Denial of absolute product protection for DNA-patents (CJ decision in Monsanto v Cefetra, C- 42808) a German perspective

  • Bird & Bird
  • -
  • European Union, Germany
  • -
  • July 27 2010

The Court of Justice of the European Communities just recently denied absolute product protection of patent claims directed to DNA sequences in the case Monsanto v Cefetra and others, C- 42808

European General Court upholds findings of abuse of dominant position by AstraZeneca for misusing the SPC and marketing authorising systems

  • Bird & Bird
  • -
  • European Union
  • -
  • July 28 2010

The European General Court issued its judgment on 1 July 2010 on AstraZeneca's appeal against the European Commission's decision adopted on 15 June 2005 fining AstraZeneca ("AZ") EUR 60 million for abuse of dominant position through misuse of the patent system to obtain supplementary protection certificates (SPCs) and misuse of the pharmaceutical regulatory system by selective withdrawal of certain marketing authorisations

Recent English case law on supplementary protection certificates and an overview of the pending references before the CJEU

  • Bird & Bird
  • -
  • European Union, United Kingdom
  • -
  • July 27 2010

In our Life Sciences Update for April 2010 we discussed, from a French perspective, the vexed question of protection for combination products under Regulation (EC) 4692009 concerning the supplementary protection certificate for medicinal products (the "SPC Regulation"

Software and business method patents recent leading European and US decisions

  • Bird & Bird
  • -
  • European Union, USA
  • -
  • August 11 2010

Recently we have had two long-awaited decisions on the patentability of software and business methods